The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(2-methyl-1-(4-(methylsulfonyl)benzyl)-1H-indol-3-yl)acetic acid ID: ALA4094939
PubChem CID: 57740764
Max Phase: Preclinical
Molecular Formula: C19H19NO4S
Molecular Weight: 357.43
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1c(CC(=O)O)c2ccccc2n1Cc1ccc(S(C)(=O)=O)cc1
Standard InChI: InChI=1S/C19H19NO4S/c1-13-17(11-19(21)22)16-5-3-4-6-18(16)20(13)12-14-7-9-15(10-8-14)25(2,23)24/h3-10H,11-12H2,1-2H3,(H,21,22)
Standard InChI Key: SPFNZISNUPAYKM-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
7.0163 -14.5939 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.6118 -13.8881 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
6.2029 -14.5913 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.7815 -11.4456 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.4425 -10.9649 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1874 -10.1859 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2201 -11.2163 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6649 -9.5227 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4780 -9.6046 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9554 -8.9414 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.8135 -10.3497 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.7829 -12.2628 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4912 -12.6702 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4890 -13.4847 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1965 -13.8921 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9046 -13.4823 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9006 -12.6609 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1925 -12.2572 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3200 -13.4781 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1191 -10.9671 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3719 -10.1940 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8293 -9.5906 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0338 -9.7590 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7838 -10.5363 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3281 -11.1364 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
20 4 1 0
4 5 1 0
5 6 2 0
6 21 1 0
5 7 1 0
6 8 1 0
8 9 1 0
9 10 2 0
9 11 1 0
4 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
16 2 1 0
2 19 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 357.43Molecular Weight (Monoisotopic): 357.1035AlogP: 3.03#Rotatable Bonds: 5Polar Surface Area: 76.37Molecular Species: ACIDHBA: 4HBD: 1#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 4.30CX Basic pKa: ┄CX LogP: 2.70CX LogD: -0.26Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.76Np Likeness Score: -1.11
References 1. Sandham DA, Barker L, Brown L, Brown Z, Budd D, Charlton SJ, Chatterjee D, Cox B, Dubois G, Duggan N, Hall E, Hatto J, Maas J, Manini J, Profit R, Riddy D, Ritchie C, Sohal B, Shaw D, Stringer R, Sykes DA, Thomas M, Turner KL, Watson SJ, West R, Willard E, Williams G, Willis J.. (2017) Discovery of Fevipiprant (NVP-QAW039), a Potent and Selective DP2 Receptor Antagonist for Treatment of Asthma., 8 (5): [PMID:28523115 ] [10.1021/acsmedchemlett.7b00157 ]